Cure My Disease

Don't miss your cure!

 Log in / Sign up

One hole or two? surgical showdown for brain bleed treatment

NCT ID NCT07688473

Disease control Sponsor: Sohag University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial compares two surgical techniques for treating chronic subdural hematoma—a slow buildup of blood between the brain and its outer covering. One group receives a single burr hole to drain the blood, while the other gets two holes. The study tracks which method leads to fewer recurrences, infections, seizures, and better overall recovery in adults.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Burr-hole craniostomy (surgical procedure)
What this could lead to
If one technique proves clearly better, it could become the standard surgical approach for chronic subdural hematoma, reducing recurrence and complications.
What could go wrong
This is a small, single-center study with only 30 participants, so results may not apply broadly. The best technique may depend on individual patient factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged ≥18 years * Radiologically confirmed chronic subdural hematoma by CT and/or MRI * Symptomatic patients indicated for surgical evacuation * Patients treated by burr-hole craniostomy (single or double) Exclusion Criteria: * Acute or subacute subdural hematomas * Patients managed by craniotomy flap * Uncorrected coagulopathy * Patients on anticoagulant or antiplatelet therapy without proper perioperative management * Patients with severe comorbid conditions significantly affecting outcomes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic subdural hematoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic subdural hematoma

Contacts and locations

Locations

  • Sohag University

    Sohag, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.